The latest research study “Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global blood plasma derivatives market size reached a value of US$ 40.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 59.8 Billion by 2027, exhibiting a CAGR of 6.40% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsample
Blood plasma derivatives refer to a concentrated form of specific proteins produced from plasma that is obtained through the fractionation process. They can be categorized into various types, such as Factor VIII, albumin, immunoglobulin, factor IX, fresh frozen, etc. Blood plasma derivatives are rich in minerals, proteins, salts, hormones, vitamins, and protease inhibitors, owing to which they are extensively utilized to kill viruses that cause hemophilia A, hepatitis B, immunodeficiency, bleeding disorders, hepatitis C, hemophilia B, human immunodeficiency virus (HIV), etc. Blood plasma derivatives also help in controlling the body temperature, improving nutrition, maintaining osmotic pressure, regulating acid-base balance, and enhancing respiration and excretion processes. Consequently, they find widespread applications in hospitals, clinics, and other healthcare facilities across countries.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Blood Plasma Derivatives Market Trends and Drivers:
The growing geriatric population, which is relatively more susceptible to developing infectious diseases, and the expanding incidences of thrombocytosis are among the key factors augmenting the blood plasma derivatives market.
Additionally, the development of numerous advanced technologies in the fractionation process, which improves the separation of protein concentrates and several other components of blood plasma for clinical purposes, is further catalyzing the market growth. Besides this, the escalating adoption of convalescent plasma treatments to treat patients suffering from COVID-19 is acting as another significant growth-inducing factor.
Furthermore, the introduction of superior preservation methods and the increasing advancements in encased procedures to develop targeted therapeutic products are expected to stimulate the blood plasma derivatives market in the coming years.
Global Blood Plasma Derivatives Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Blood Plasma Derivatives Companies:
Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/blood-plasma-derivatives-market
The report has segmented the market on the basis of region, type, application and end user.
Breakup by Type:
- Factor VIII
- Factor IX
- Hyperimmune Globulin
Breakup by Application:
- Immunodeficiency Diseases
- Von Willebrand’s Disease
Breakup by End User:
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800